Literature DB >> 16986122

A common variant located in the 3'UTR of the RET gene is associated with protection from Hirschsprung disease.

Paola Griseri1, Francesca Lantieri, Francesca Puppo, Tiziana Bachetti, Marco Di Duca, Roberto Ravazzolo, Isabella Ceccherini.   

Abstract

Complex diseases are common genetic disorders showing familial aggregation but no typical Mendelian inheritance. Hirschsprung disease (HSCR), a developmental disorder characterized by the absence of enteric neurons in distal segments of the gut, shows a complex pattern of inheritance, with the RET protooncogene acting as a major gene and additional susceptibility loci playing minor roles. In the last years, we have identified a "protective" RET haplotype, which is underrepresented in HSCR patients with respect to controls. Here, we demonstrate that the protective effect of this haplotype is due to a variant located in the 3' untranslated region (UTR) of the RET gene, which slows down the physiological mRNA decay of the gene transcripts. Such a functional effect of this common RET variant explains the under-representation of the whole haplotype and its role as a modifying factor in HSCR pathogenesis. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16986122     DOI: 10.1002/humu.20397

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  15 in total

Review 1.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

2.  RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.

Authors:  V Neocleous; N Skordis; G Portides; E Efstathiou; C Costi; N Ioannou; M Pantzaris; V Anastasiadou; C Deltas; L A Phylactou
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

Review 3.  Genetic model system studies of the development of the enteric nervous system, gut motility and Hirschsprung's disease.

Authors:  G Burzynski; I T Shepherd; H Enomoto
Journal:  Neurogastroenterol Motil       Date:  2009-02       Impact factor: 3.598

4.  RET polymorphisms and the risk of Hirschsprung's disease in a Chinese population.

Authors:  Cuiping Liu; Lei Jin; Hui Li; Jintu Lou; Chunfen Luo; Xuewu Zhou; Ji-Cheng Li
Journal:  J Hum Genet       Date:  2008-07-08       Impact factor: 3.172

Review 5.  The developmental etiology and pathogenesis of Hirschsprung disease.

Authors:  Naomi E Butler Tjaden; Paul A Trainor
Journal:  Transl Res       Date:  2013-03-22       Impact factor: 7.012

Review 6.  Chromosomal and related Mendelian syndromes associated with Hirschsprung's disease.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2012-09-23       Impact factor: 1.827

7.  Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice.

Authors:  Toshihiro Uesaka; Mayumi Nagashimada; Shigenobu Yonemura; Hideki Enomoto
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 8.  Mouse models of Hirschsprung disease and other developmental disorders of the enteric nervous system: Old and new players.

Authors:  Nadege Bondurand; E Michelle Southard-Smith
Journal:  Dev Biol       Date:  2016-06-28       Impact factor: 3.582

9.  Methylation analysis of EDNRB in human colon tissues of Hirschsprung's disease.

Authors:  Weibing Tang; Bo Li; Junwei Tang; Kang Liu; Jingjing Qin; Wei Wu; Qiming Geng; Jie Zhang; Huan Chen; Xiaoqun Xu; Yankai Xia
Journal:  Pediatr Surg Int       Date:  2013-04-12       Impact factor: 1.827

10.  Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.

Authors:  Simonetta Bandiera; François Cartault; Anne-Sophie Jannot; Elie Hatem; Muriel Girard; Laila Rifai; Clemence Loiseau; Arnold Munnich; Stanislas Lyonnet; Alexandra Henrion-Caude
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.